New salts of photochromic indoline spiropyrans capable of reversibly responding to UV radiation were synthesized to develop light-controlled materials. Photoinduced reactions of the synthesized compounds were studied using absorption and luminescence spectroscopies, and the quantum yields of photoisomerization and other spectral and kinetic characteristics were measured. It was shown that the light sensitivity and photostability of the synthesized compounds are considerably influenced by the length of the spacer between the indole and ammonium nitrogen atoms.
Hybrid molecules based on fullerene C60 and dithienylethene and its perfluorinated analog not inferior in the efficiency of phototransformations to the initial photochromic compounds were synthesized for the first time. The resulting pyrrolidinofullerenes containing photochromic moieties were used to fabricate organic field‐effect transistors (OFETs) with output and transfer characteristics ten times exceeding similar characteristics of devices based on staring dithienylethenes. It was found that OFETs based on hybrid molecules with dithienylethenes are four times less efficient than devices based on hybrid molecules with perfluorinated analogs.
The present research addresses synthesis of methanofullerenes containing 5Z,9Z-dienoic acid molecules applying the Bingel and Bingel-Hirsch reactions. The cytotoxic activity of the synthesized methanofullerenes against Jurkat, K562, U937, HL60 tumour cells was under study. Hybrid methanofullerenes containing dienoic acids were found to exhibit high in vitro cytotoxicity against these tumour cell lines, produce phasespecific cytotoxic effect during the S and G2 phases of the cell cycle, and are also effective inducers of apoptosis.Building effective systems for targeted drug delivery in the development of anticancer drugs is one of the major challenges of modern pharmacology. This is due to the fact that most antitumor drugs are highly toxic and lack specificity, meaning that these treatments affect both cancer cells and their normal counterparts.No coincidence is the fact that the range of nanoscale delivery vectors of anticancer drugs has expanded significantly since the discovery of fullerenes in 1985. The size, shape and high lipophilicity of C 60 fullerene enable it to penetrate rather easily through cell membranes and are an ideal combination of properties for use as a vector for targeted drug delivery.To date, the transport properties of C 60 fullerene have been successfully demonstrated on a wide range of different pharmaceutical products and anticancer drugs. A perfect example of the use of C 60 fullerene as a means of anticancer drug delivery with the aim of increasing their selectivity is the production of complexes and hybrids with doxorubicin. [1][2][3][4][5][6][7][8] Individual doxorubicin is characterized by low selectivity and cardiotoxicity, its fullerene complex increases both the rate of penetration into cancer cells by 20-30% and the effectiveness increases by 1.5-2 times. [1] The conjugate of doxorubicin with C 60 reduces the tumor volume by 40-60% in vivo compared to an individual doxorubicin, thus increasing life expectancy of mice by 2.5 times. [1,2] Furthermore, enhanced efficiency of the conjugate does not increase the side effects of the initial preparation. [4,5] Chemical binding of C 60 fullerene and its derivatives with doxorubicin does not produce obvious therapeutic effect of this kind, [6,7] but there is still a significant decline in the toxicity of the initial anticancer drug. [7] The main difference between the hybrid and the original doxorubicin molecules is that the hybrid, after penetrating the cell, primarily accumulates in the cytoplasm, and not in the nucleus. [8] Along with doxorubicin, C 60 fullerene complexes and hybrids were also prepared with paclitaxel, [9,10] docetaxel, [11 ] and cisplatin. [12,13] Increased effectiveness of the corresponding drugs was reached with achieved both in vivo and in vitro experiments. Meanwhile, when comparing the therapeutic effect, a considerable decline in the toxicity of these drugs was registered as well.Recently, our research group developed an efficient onepot method for the synthesis of 5Z,9Z-dienoic acids with a yield of ∼ 70% an...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.